Cargando…

The Effectiveness of the Use of Regdanvimab (CT-P59) in Addition to Remdesivir in Patients with Severe COVID-19: A Single Center Retrospective Study

Introduction: Coronavirus disease 2019 (COVID-19) still has a high mortality rate when it is severe. Regdanvimab (CT-P59), a neutralizing monoclonal antibody that has been proven effective against mild to moderate COVID-19, may be effective against severe COVID-19. This study was conducted to determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chae, Ganghee, Choi, Aram, Lim, Soyeoun, Park, Sooneun, Lee, Seungjun, Ahn, Youngick, Kim, Jinhyoung, Ra, Seungwon, Jegal, Yangjin, Ahn, Jongjoon, Park, Eunji, Jun, Jaebum, Kwon, Woonjung, Lee, Taehoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950958/ https://www.ncbi.nlm.nih.gov/pubmed/35324598 http://dx.doi.org/10.3390/tropicalmed7030051

Ejemplares similares

A fatal case report of invasive pulmonary aspergillosis and mucormycosis coinfection in an immunocompetent patient with coronavirus disease 2019 in Korea
por: Kim, Jin Hyoung, et al.
Publicado: (2023)

Histiocytic pleural effusion: the strong clue to malignancy
por: Chae, Ganghee, et al.
Publicado: (2021)

Regdanvimab: First Approval
por: Syed, Yahiya Y.
Publicado: (2021)

Diagnosing peripheral lung lesions using endobronchial ultrasonography with guide sheath: A prospective registry study to assess the effect of virtual bronchoscopic navigation using a computed tomography workstation
por: Bae, Soohyun, et al.
Publicado: (2020)

Correction to: Regdanvimab: First Approval
por: Syed, Yahiya Y.
Publicado: (2021)

Regdanvimab Treatment of COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Gynecomastia induced by H1-antihistamine (ebastine) in a patient with idiopathic anaphylaxis
por: Jung, Hwa Sik, et al.
Publicado: (2015)

The mechanical characteristics and performance evaluation of a newly developed silicone airway stent (GINA stent)
por: Jung, Hwa Sik, et al.
Publicado: (2021)

Reduced Diffusing Capacity in Humidifier Disinfectant-Associated Asthma Versus Typical Asthma: A Retrospective Case Control Study
por: Pak, Chuiyong, et al.
Publicado: (2022)

Clinical outcomes of mild to moderate coronavirus disease 2019 patients treated with Regdanvimab in delta-variant outbreak: Retrospective cohort study
por: Noh, Hyeong-Jun, et al.
Publicado: (2023)

Early Oxygen Requirement in Patients with Mild-to-Moderate COVID-19 Who Received Regdanvimab after Delta-Variant Outbreak
por: Lee, Chan Mi, et al.
Publicado: (2022)

Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea
por: Lee, Ji Yeon, et al.
Publicado: (2023)

Elucidation of Bacterial Pneumonia-Causing Pathogens in Patients with Respiratory Viral Infection
por: Jung, Hwa Sik, et al.
Publicado: (2017)

Corrigendum: Elucidation of Bacterial Pneumonia-Causing Pathogens in Patients with Respiratory Viral Infection
por: Jung, Hwa Sik, et al.
Publicado: (2018)

Effectiveness and Safety of Regdanvimab in Patients With Mild-To-Moderate COVID-19: A Retrospective Cohort Study
por: Park, Susin, et al.
Publicado: (2022)

Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19
por: Kim, Taeyun, et al.
Publicado: (2022)

Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019
por: Streinu-Cercel, Anca, et al.
Publicado: (2022)

Effectiveness of Regdanvimab at Preventing the Need for Oxygen Therapy in Patients with Mild-to-Moderate COVID-19: A Retrospective Cohort Study
por: Choi, Seong Jin, et al.
Publicado: (2022)

GSPE Protects against Bleomycin-Induced Pulmonary Fibrosis in Mice via Ameliorating Epithelial Apoptosis through Inhibition of Oxidative Stress
por: Sul, Ok Joo, et al.
Publicado: (2022)

Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease
por: Lee, Ji Yeon, et al.
Publicado: (2021)

The role of neutrophils in the pathogenesis of IPF
por: Jegal, Yangjin
Publicado: (2022)

Active tuberculosis risk associated with malignancies: an 18-year retrospective cohort study in Korea
por: Cheon, Jaekyung, et al.
Publicado: (2020)

Non-infected and Infected Bronchogenic Cyst: The Correlation of Image Findings with Cyst Content
por: Jeon, Hong Gil, et al.
Publicado: (2014)

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
por: Kim, Jin Yong, et al.
Publicado: (2022)

Clinical Importance of Work-Exacerbated Asthma: Findings From a Prospective Asthma Cohort in a Highly Industrialized City in Korea
por: Jo, Woori, et al.
Publicado: (2020)

A Case of Alveolar Soft Part Sarcoma of the Pleura
por: Ju, Hyeong Uk, et al.
Publicado: (2013)

Use of the Monoclonal Antibody Regdanvimab to Treat Patients Hospitalized with COVID-19: Real-World Data during the Delta Variant Predominance
por: Kwak, Yee Gyung, et al.
Publicado: (2022)

A Case of Atypical Skull Base Osteomyelitis with Septic Pulmonary Embolism
por: Lee, Soon Jung, et al.
Publicado: (2011)

Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis
por: Yang, Mingyang, et al.
Publicado: (2022)

Systemic Immune-Inflammation Index Predicted Short-Term Outcomes in Patients Undergoing Isolated Tricuspid Valve Surgery
por: Yoon, Jungpil, et al.
Publicado: (2021)

Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man
por: Day, Leora Branfield, et al.
Publicado: (2021)

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia
por: Lee, Jongmin, et al.
Publicado: (2019)

Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study
por: Jang, Young Rock, et al.
Publicado: (2022)

The Combination of Real-Time PCR and HPLC for the Identification of Non-Tuberculous Mycobacteria
por: Park, Jae Sun, et al.
Publicado: (2013)

Regdanvimab in patients with mild-to-moderate SARS-CoV-2 infection: A propensity score–matched retrospective cohort study
por: Lee, Shinwon, et al.
Publicado: (2022)

Hemothorax caused by spontaneous rupture of a metastatic mediastinal lymph node in hepatocellular carcinoma: a case report
por: Oh, Ssang Yong, et al.
Publicado: (2013)

Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?
por: Marcec, Robert, et al.
Publicado: (2023)

Stable nebulization and muco‐trapping properties of regdanvimab/IN‐006 support its development as a potent, dose‐saving inhaled therapy for COVID‐19
por: McSweeney, Morgan D., et al.
Publicado: (2022)

Effects of creative dance-based exercise on gait performance in adolescents with cerebral palsy
por: Joung, Hee Joung, et al.
Publicado: (2020)

Correction to: A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q7cjfv063gdbshmn6ktpnctmqr